Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8525 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8268 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8208 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8208 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.815 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8142 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8142 |
Intermediate Similarity |
NPD8313 |
Approved |
0.814 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8136 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.809 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8087 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8066 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8035 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8033 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8011 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.799 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7978 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7965 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7926 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7912 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7849 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7839 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7839 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7835 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7809 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7772 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7771 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7746 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7746 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7746 |
Intermediate Similarity |
NPD2534 |
Approved |
0.773 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7719 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7716 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7716 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7716 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7709 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7709 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7677 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7672 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7612 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7577 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7577 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7571 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD37 |
Approved |
0.7443 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7418 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7418 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7418 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7411 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7384 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7384 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7384 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7337 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7312 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7312 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD919 |
Approved |
0.7225 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7176 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7166 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7166 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7166 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7164 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7104 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD1240 |
Approved |
0.709 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7085 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7085 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD920 |
Approved |
0.707 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD8366 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7028 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD7095 |
Approved |
0.701 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.6994 |
Remote Similarity |
NPD1613 |
Approved |
0.6994 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD2438 |
Suspended |
0.6977 |
Remote Similarity |
NPD7985 |
Registered |
0.6977 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6965 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD4665 |
Approved |
0.6963 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6961 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6955 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.694 |
Remote Similarity |
NPD1653 |
Approved |
0.6927 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8491 |
Approved |
0.6923 |
Remote Similarity |
NPD6765 |
Approved |
0.6923 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6764 |
Approved |
0.6923 |
Remote Similarity |
NPD7584 |
Approved |
0.6898 |
Remote Similarity |
NPD4288 |
Approved |
0.6895 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6895 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6879 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6872
|
Remote Similarity |
NPD1243 |
Approved |